Compounds > 5-(4-acetamidophenyl)pyrazin-2(1h)-one
Page last updated: 2024-09-03

5-(4-acetamidophenyl)pyrazin-2(1h)-one and calmidazolium

5-(4-acetamidophenyl)pyrazin-2(1h)-one has been researched along with calmidazolium in 1 studies

Compound Research Comparison

Studies
(5-(4-acetamidophenyl)pyrazin-2(1h)-one)		Trials
(5-(4-acetamidophenyl)pyrazin-2(1h)-one)		Recent Studies (post-2010)
(5-(4-acetamidophenyl)pyrazin-2(1h)-one)		Studies
(calmidazolium)		Trials
(calmidazolium)		Recent Studies (post-2010) (calmidazolium)
3800550039

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bryson, SE; Rodger, IW1

Other Studies

1 other study(ies) available for 5-(4-acetamidophenyl)pyrazin-2(1h)-one and calmidazolium

ArticleYear
Effects of phosphodiesterase inhibitors on normal and chemically-skinned isolated airway smooth muscle.
    British journal of pharmacology, 1987, Volume: 92, Issue:3

    Topics: 1-Methyl-3-isobutylxanthine; Airway Resistance; Animals; Cyclic AMP; Cyclic GMP; Guinea Pigs; Histamine; Imidazoles; In Vitro Techniques; Male; Papaverine; Phosphodiesterase Inhibitors; Protein Kinases; Pyrazines

1987